Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Through 2029?

The market size of transfection technologies has seen significant growth in the previous years. The market’s value is projected to increase from $1.21 billion in 2024 to $1.31 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 8.3%. This growth during the historical period is due to factors such as increased occurrence of chronic diseases, broadened use of transfection technologies, heightened demand for cell & gene therapy, an increase in R&D investments, and a surge in cancer cases.

In the coming years, the market size for transfection technologies is predicted to experience robust growth, soaring to “$1.83 billion by 2029 with a yearly average growth rate of 8.8%. This growth during the forecasted period could be due to the surge in chronic and immunological diseases, an increased necessity for cell-centered treatments, growing demand for protein manufacturing, escalating investments and resources funneled towards the creation of drug delivery systems, and a rise in the need for monoclonal antibodies. The projection period also sees a rising trend in research and development in cell-oriented treatments, embracing advanced methods in transfection, a rise in the demand for advanced therapeutic delivery systems, an increased practice of dual-reporter assays and co-transfection studies, and an intensified emphasis on personalized medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

What Market Forces Are Driving The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Sector In 2025 And Beyond?

The expansion of the pharmaceutical contract development and manufacturing market is fueled by the rising global demand for medications. The broad prevalence of diseases and the desire for a longer lifespan has heightened the requirement for medications, compelling pharmaceutical manufacturers to boost the production of existing drugs and escalate investment in research and development for new drug exploration. This compels these firms to partner with contract manufacturing organizations (CMOs), as a strategy to reduce operational expenditures, subsequently increasing the need for pharmaceutical contract development and manufacturing market. Based on information from Alkermes PLC., a biopharmaceutical firm, pharmaceutical contract manufacturing is likely to become a strategic choice for a variety of companies, from large-scale to smaller niche pharmaceutical entities, principally due to pharmaceutical companies’ pursuit of cost reduction.

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

How Are Key Trends Driving Expansion In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Industry?

Leading transfection technologies market players are directing their efforts towards the creation of sophisticated technology like mechanoporation transfection systems. These systems facilitate highly complex and tailored applications within research and therapeutic fields. The unique process of mechanoporation transfection involves mechanical forces opening temporary pores in cellular membranes to enable entry of genetic elements. This method allows for greater efficiency and less invasiveness, thus ensuring cell vitality. A case in point, STEMCELL Technologies, a biotech firm from Canada, unveiled its revolutionary transfection system, CellPore, in July 2024. This system constitutes a benchtop unit and a CellPore Transfection Kit 300. It’s equipped with a specific reagent set and one-time use delivery cartridges. By triggering controlled, quick deformation in microfluidic channels, CellPore can effectively transport small molecules, nucleic acids, proteins, and gene editing structures into cells. It ensures low cellular disruption and high survival, characteristics key for propelling research and innovating cell and gene therapies.

Which Firms Are Considered Leaders In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Space?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

What Role Do Regional Policies And Investments Play In Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Expansion?

North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model